Compounds > phenylalanyl-phenylalanyl-glycine
Page last updated: 2024-12-07
phenylalanyl-phenylalanyl-glycine
Description
phenylalanyl-phenylalanyl-glycine: RN given refers to (D-Phe-L-Phe)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
Synonyms (8)
Synonym |
2-[[(2s)-2-[[(2s)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]acetic acid |
phe-phe-gly |
75539-83-2 |
CHEBI:161765 |
phenylalanyl-phenylalanyl-glycine |
glycine, n-(n-d-phenylalanyl-l-phenylalanyl)- |
DTXSID30226473 |
l-phenylalanyl-l-phenylalanyl-glycine |
Drug Classes (1)
Class | Description |
oligopeptide | A peptide containing a relatively small number of amino acids. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |